Monocyte chemotactic protein-1 and other inflammatory parameters in Bernese Mountain dogs with disseminated histiocytic sarcoma

Veterinary Journal

Volumn 198, Issue 2, 2013, Pages 424-428

  Nikolic Nielsen, Lise ^a   Kjelgaard Hansen, Mads ^b   Kristensen, Annemarie T ^b  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acute phase proteins; Cytokines; Disseminated histiocytic sarcoma; Dog; Monocyte chemotactic protein (MCP 1)

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISSEMINATED HISTIOCYTIC SARCOMA; DOG; FEMALE; HISTIOCYTIC SARCOMA; IMMUNE STATUS; LEUKOCYTE COUNT; MALE; MONOCYTE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

CANIS FAMILIARIS;

ACUTE PHASE PROTEINS; CYTOKINES; DISSEMINATED HISTIOCYTIC SARCOMA; DOG; MONOCYTE CHEMOTACTIC PROTEIN (MCP-1);

ACUTE-PHASE PROTEINS; ANIMALS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CYTOKINES; DOG DISEASES; DOGS; FEMALE; HISTIOCYTIC SARCOMA; LEUKOCYTES; MALE; PROSPECTIVE STUDIES; SPECIES SPECIFICITY;

EID: 84888431788     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.07.030     Document Type: Article

References (35)

1. Abadie J., Hedan B., Cadieu E., De Brito C., Devauchelle P., Bourgain C., Parker H.G., Vaysse A., Margaritte-Jeannin P., Galibert F., et al. Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed. Journal of Heredity 2009, 100:S19-S27.
2. Affolter V.K., Moore P.F. Canine cutaneous and systemic histiocytosis: Reactive histiocytosis of dermal dendritic cells. American Journal of Dermatopathology 2000, 22:40-48.
3. Affolter V.K., Moore P.F. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Veterinary Pathology 2002, 39:74-83.
4. Burgdorf S.K., Claesson M.H., Nielsen H.J., Rosenberg J. Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination. Acta Oncology 2009, 48:1157-1164.
5. Ceron J.J., Eckersall P.D., Martínez-Subiela S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Veterinary Clinical Pathology 2005, 34:85-99.
6. Conti I., Rollins B.J. CCL2 (monocyte chemoattractant protein-1) and cancer. Seminars in Cancer Biology 2004, 14:149-154.
7. Coomber A.R., Liptak J.M. Canine histiocytic diseases. Compendium on Continuing Education for the Practicing Veterinarian 2008, 4:202-204.
8. Dehqanzada Z.A., Storrer C.E., Hueman M.T., Foley R.J., Harris K.A., Jama Y.H., Shriver C.D., Ponniah S., Peoples G.E. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncology Reports 2007, 17:687-694.
9. Duffy A.L., Olea-Popelka F.J., Eucher J., Rice D.M., Dow S.W. Serum concentrations of monocyte chemoattractant protein-1 in healthy and critically ill dogs. Veterinary Clinical Pathology 2010, 39:302-305.
10. Dwivedi S., Goel A., Natu S.M., Mandhani A., Khattri S., Pant K.K. Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: A prospective study. Asian Pacific Journal of Cancer Prevention 2011, 12:1843-1848.
11. He G., Holcroft C.A., Beauchamp M.C., Yasmeen A., Ferenczy A., Kendall-Dupont J., Mes-Masson A.M., Provencher D., Gotlieb W.H. Combination of serum biomarkers to differentiate malignant from benign ovarian tumours. Journal of Obstetrics and Gynaecology Canada 2012, 34:567-574.
12. Imashuku S., Okuda T., Yoshihara T., Ikushima S., Hibi S. Cytokine levels in aggressive natural killer cell leukemia and malignant histiocytosis. British Journal of Haematology 1991, 79:132-133.
13. Itoh H., Horiuchi Y., Nagasaki T., Sakonju I., Kakuta T., Fukushima U., Uchide T., Yamashita M., Kuwabara M., Yusa S., et al. Evaluation of immunological status in tumor-bearing dogs. Veterinary Immunology and Immunopathology 2009, 132:85-90.
14. Jones S.A. Directing transition from innate to acquired immunity: Defining a role for IL-6. Journal of Immunology 2005, 175:3463-3468.
15. Kim J.H., Yu C.H., Yhee J.Y., Im K.S., Sur J.H. Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. Journal of Comparative Pathology 2010, 142:177-186.
16. Kjelgaard-Hansen M. Comments on evaluation of three automated human immunoturbidimetric assays for the detection of C-reactive protein in dogs. Veterinary Clinical Pathology 2010, 39:402-404.
17. Kjelgaard-Hansen M., Goggs R., Wiinberg B., Chan D.L. Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs. Journal of Veterinary Internal Medicine 2011, 25:76-82.
18. Kjelgaard-Hansen M., Jensen A.L. Is the inherent imprecision of manual leukocyte differential counts acceptable for quantitative purposes?. Veterinary Clinical Pathology 2006, 35:268-270.
19. Kjelgaard-Hansen M., Jensen A.L., Kristensen A.T. Evaluation of a commercially available human C-reactive protein (CRP) turbidometric immunoassay for determination of canine serum CRP concentration. Veterinary Clinical Pathology 2003, 32:81-87.
20. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. Journal of Clinical Investigations 2007, 117:1175-1183.
21. Lu X., Qian C.N., Mu Y.G., Li N.W., Li S., Zhang H.B., Li S.W., Wang F.L., Guo X., Xiang Y.Q. Serum CCL2 and serum TNF-alpha - Two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma. European Journal of Cancer 2011, 47:339-346.
22. Lv M., Xiaoping X., Cai H., Li D., Wang J., Fu X., Yu F., Sun M., Lv Z. Cytokines as prognostic tool in breast carcinoma. Frontiers in Biosciences 2011, 17:2515-2526.
23. Manderson A.P., Kay J.G., Hammond L.A., Brown D.L., Stow J.L. Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFα. The Journal of Cell Biology 2007, 178:57-69.
24. Moore P.F., Affolter V.K., Vernau W. Canine hemophagocytic histiocytic sarcoma: A proliferative disorder of CD11d+ macrophages. Veterinary Pathology 2006, 43:632-645.
25. Moore P.F., Rosin A. Malignant histiocytosis of Bernese mountain dogs. Veterinary Pathology 1986, 23:1-10.
26. Negus R.P., Stamp G.W., Relf M.G., Burke F., Malik S.T., Bernasconi S., Allavena P., Sozzani S., Mantovani A., Balkwill F.R. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. Journal of Clinical Investigation 1995, 95:2391-2396.
27. Nielsen L., Kjelgaard-Hansen M., Jensen A.L., Kristensen A.T. Breed-specific variation of hematologic and biochemical analytes in healthy adult Bernese Mountain dogs. Veterinary Clinical Pathology 2010, 39:20-28.
28. Nikolic Nielsen L., McEvoy F., Rem Jessen L., Kristensen A.T. Investigation of a screening programme and the possible identification of biomarkers for early disseminated histiocytic sarcoma in Bernese Mountain dogs. Veterinary Comparative Oncology 2012, 2012:124-134.
29. Nikolic Nielsen L., Wiinberg B., Kjelgaard Hansen M., Jensen A.L., Kristensen A.T. Prolonged activated prothromboplastin time and breed specific variation in haemostatic analytes in healthy adult Bernese Mountain dogs. The Veterinary Journal 2011, 190:150-153.
30. Padgett G.A., Madewell B.R., Keller E.T., Jodar L., Packard M. Inheritance of histiocytosis in Bernese mountain dogs. Journal Small Animal Practice 1995, 36:93-98.
31. Perry J.A., Thamm D.H., Eickhoff J., Avery A.C., Dow S.W. Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma. Veterinary Comparative Oncology 2011, 9:55-64.
32. Qian B.Z., Li J., Zhang H., Kitamura T., Zhang J., Campion L.R., Kaiser E.A., Snyder L.A., Pollard J.W. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475:222-225.
33. Soare T., Noble P.J., Hetzel U., Fonfara S., Kipar A. Paraneoplastic syndrome in haemophagocytic histiocytic sarcoma in a dog. Journal of Comparative Pathology 2011, 10.1016/j.jcpa.2011.05.006.
34. Yurkovetsky Z.R., Kirkwood J.M., Edington H.D., Marrangoni A.M., Velikokhatnaya L., Wnans M.T., Gorelik E., Lokshin A.E. Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b. Clinical Cancer Research 2007, 13:2422-2428.
35. Zois N.E., Moesgaard S.G., Kjelgaard-Hansen M., Rasmussen C.E., Falk T., Fossing C., Haggstrom J., Pedersen H.D., Olsen L.H. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease. The Veterinary Journal 2012, 192:106-111.